Cost-Effectiveness of Apixaban versus Other Direct Oral Anticoagulants and Warfarin in the Prevention of Thromboembolic Complications Among Finnish Patients with Non-Valvular Atrial Fibrillation
Author:
Publisher
Informa UK Limited
Subject
Health Policy,Economics, Econometrics and Finance (miscellaneous)
Reference47 articles.
1. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
2. Working group set up by the Finnish Medical Society Duodecim and the Finnish Cardiac Society. Atrial fibrillation. Current care guidelines. Helsinki: The Finnish Medical Society Duodecim; 2017. (referred February 5, 2021). Available from: www.kaypahoito.fi. Accessed March 16, 2021.
3. Apixaban versus Warfarin in Patients with Atrial Fibrillation
4. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
5. Dabigatran versus Warfarin in Patients with Atrial Fibrillation
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Apixaban for Children With Heart Disease;Journal of the American College of Cardiology;2023-12
2. Methods for Economic Evaluations of Novel Oral Anticoagulants in Patients with Atrial Fibrillation: A Systematic Review;Applied Health Economics and Health Policy;2023-10-29
3. Comparative pharmacoeconomic analysis of the use of apixaban, rivaroxaban and dabigatran for prevention of stroke and embolism in the vessels of the systemic circulation in patients with non-valvular atrial fibrillation;Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice;2023-03-01
4. Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Systematic Review of Economic Evaluations;Value in Health Regional Issues;2023-01
5. Cost-Effectiveness of Empagliflozin in Combination with Standard Care versus Standard Care Only in the Treatment of Heart Failure Patients in Finland;ClinicoEconomics and Outcomes Research;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3